• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.26%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    2.66 Up 0.10(3.71%) 1:03PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.56
    Open:2.59
    Bid:2.65 x 4500
    Ask:2.66 x 5600
    1y Target Est:7.38
    Beta:-0.66001
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:2.57 - 2.68
    52wk Range:2.55 - 6.28
    Volume:869,523
    Avg Vol (3m):2,736,320
    Market Cap:643.15M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 3.71%643.15M
    OREXUp 2.99%346.09M
    GSKUp 2.25%97.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.50
    Quarterly EPS Est (Sep-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback